[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Botha et al., 1976 - Google Patents

Gastric inhibitory polypeptide (GIP) in chronic pancreatitis

Botha et al., 1976

Document ID
3574008285729123927
Author
Botha J
Vinik A
Brown J
Publication year
Publication venue
The Journal of Clinical Endocrinology & Metabolism

External Links

Snippet

The plasma gastric inhibitory polypeptide (GIP), pancreatic glucagon-like immunoreactivity (PGLI), andgutglucagon-likeimmunoreactivity (GGLI) responses to oral glucose have been measured in five patients with chronic pancreatitis (with diabetic glucose tolerance tests) …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Similar Documents

Publication Publication Date Title
SALERA et al. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity
Schusdziarra et al. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog
Andersen et al. Oral glucose augmentation of insulin secretion: interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels
Chiba et al. Effects of various gastrointestinal peptides on gastric somatostatin release
Weir et al. Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine
Adrian et al. Inhibition of secretin stimulated pancreatic secretion by pancreatic polypeptide.
Liddle et al. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.
Sarson et al. A radioimmunoassay of gastric inhibitory polypeptide in human plasma
Bloom et al. Gut hormones
LAMERS et al. Mechanism of elevated serum pancreatic polypeptide concentrations in chronic renal failure
Rehfeld Disturbed islet-cell function related to endogenous gastrin release. Studies on insulin secretion and glucose tolerance in pernicious anemia.
D'Alessio et al. A physiologic role for somatostatin 28 as a regulator of insulin secretion.
Miazza et al. Jejunal secretory effect of intraduodenal food in humans: A comparison of mixed nutrients, proteins, lipids, and carbohydrates
Botha et al. Gastric inhibitory polypeptide (GIP) in chronic pancreatitis
SIVE et al. Impaired pancreatic polypeptide secretion in chronic pancreatitis
Ensinck et al. Circulating prosomatostatin-derived peptides. Differential responses to food ingestion.
Kilander et al. Plasma enteroglucagon related to malabsorption in coeliac disease.
Hopman et al. Plasma cholecystokinin response to a liquid fat meal in vagotomized patients
AKIHIRO et al. Evidence for cholinergic and vagal noncholinergic mechanisms modulating plasma motilin-like immunoreactivity
Pedersen et al. Neurotensin-like immunoreactivities in human plasma: feeding responses and metabolism
Cataland et al. Stimulation of gastric inhibitory polypeptide in normal and duodenal ulcer patients
Olesen et al. Importance of Colonic Bacterial Fermentation in Short Bowel Patients (Small Intestinal Malabsorption of Easily Digestible Carbohydrate)
de Jong et al. Effect of rabbit anti-pancreatic polypeptide serum on postprandial pancreatic exocrine secretion in dogs
BOTHA et al. Gastric inhibitory polypeptide in acquired pancreatic diabetes: effects of insulin treatment
Bajorunas et al. Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans: paradoxical response to oral glucose